Background: Due to the limited data comparing treatment outcomes of simple liver cysts (SLCs), there is, at present, no consensus on the optimum surgical treatment method for symptomatic SLCs. The objective of this paper was to review the outcomes for surgically managed SLCs carried out at our institution.
Introduction
Liver cysts may arise from the biliary tree or from hepatic tissue. Liver cysts include non-parasitic simple liver cysts (SLCs), multiple cysts that occupy less than 50% of the liver volume, polycystic disease that occupies more than 50% of the liver volume and acquired cysts, which may be the result of parasitic, bacterial, or amoebic infection. Proliferative lesions or tumors may also arise, including cystadenocarcinomas, or benign like cystadenomas [1] .
The incidence of SLC is 2.5-5% [2] [3] [4] [5] . The vast majority of SLC are asymptomatic and the diagnosis of SLC is generally an incidental finding on abdominal imaging or abdominal surgery for unrelated pathology. There is a female preponderance for symptomatic SLC, with a ratio of 9:1 [4, [6] [7] [8] . The prevalence of SLC is higher in females, and is markedly increased between the ages of 40 and 60 years, as reported by Caremani et al [9] . The 5-10% of SLC that present with symptoms do so because of mechanical compression, rupture, hemorrhage into the cyst, or infection [10] .
SLCs are usually thin-walled without mural nodules or papillary projections. Septa are absent, giving rise to a unilocular clear cyst. Asymptomatic SLC is managed conservatively. Once symptoms or complications develop, surgical options may include fenestration and resection of the cyst using a laparoscopic or open approach. Other alternatives include percutaneous aspiration and alcohol sclerotherapy but these are less effective and have a high recurrence rate of 100% and 75% respectively [1, 2, 4, 6] .
Due to the limited number of patients and follow-up SNP data available, comparisons of the various operative techniques have been sub-optimal and the optimum surgical management of SLC has not been clearly established [1] [3, 5, [11] [12] [13] [14] [15] . This study evaluates our experience in a single-center over 10 years to determine the optimum operative treatment for SLC.
Methods
Institutional ethics approval was obtained for this study. Twenty-eight patients with a preoperative diagnosis of SLC who underwent surgical treatment at our institution between January 2003 and December 2012 were identified by cross-referencing our surgical and pathology databases. Patient demographics, perioperative parameters, final histopathology, and long-term outcomes were reviewed. Patient morbidity was graded using Dindo-Clavien's classification system [16] . Preoperative blood CA 19-9 and CEA was obtained in seven patients. Cyst fluid aspiration was performed in 11 patients. The cyst fluid was assayed for CA 19-9 in only one patient. Preoperative computer tomography (CT) of the lesion was carried out in all but one patient. Preoperative MRI was performed in six patients. All patients had preoperative ultrasonography examinations. These imaging tests were designed to test parameters including the presence of multilocularity, septa, mural nodules, papillary projections or any other solid component in the tumor, which are classically markers of nonsimple cysts. Other criteria were the presence of calcification, increased vascularity, and cyst wall enhancement following wall contrast injection.
Percutaneous drainage was attempted two times in one patient, and one other percutaneous drainage procedure was performed. The types of surgery were classified by the approach as laparoscopic, laparoscopic converted to open surgery, and open surgery. The surgical procedures used in each case were recorded from the operative notes. The procedures included fenestration, segmental resection, bisegmentectomy, and hemi-hepatectomy. Frozen section was performed in two cases. Operative mortality was defined as death within 90 days of the surgical procedure.
Length of follow-up was from the date of the procedure to the date of the last imaging result, or date of last clinical review, within our institution or affiliates. Follow-up was performed by clinical examination and laboratory studies. Additional investigations including ultrasound (US) of the abdomen was performed depending on the clinical indication. Patients were contacted by telephone and asked to corroborate the most recent cyst recurrence status.
Cyst recurrence was defined as symptomatic recurrence or radiological/asymptomatic recurrence of the same type of cyst in the same spot or another location.
Results
Between January 2003 and December 2012, 28 patients underwent surgical intervention for a preoperative diagnosis of SLC at our institution. The mean age at surgery was 58.2 (SD ± 13.7, range 18 -74 years). There were 24 female and four male patients. Of the 28 patients, four patients (14.3%) were asymptomatic on presentation. Twenty-four patients presented with initial symptoms, of which abdominal pain (71.4%), abdominal fullness (17.9%), nausea and vomiting (14.3%) were most typical. Other symptoms included early satiety, back pain, dyspnea and cough [1] .
Preoperative CA 19-9 and CEA values from seven patients ranged between less than 2 -105 ng/dL and 0.6 -9 IU/mL. There was no clear cut-off between an SLC, cystadenoma, or cystadenocarcinoma based on these measurements.
Preoperative abdominal US testing and CT assessment were performed on 28 and 27 patients respectively. These revealed the presence of multilocular cysts in 14 (51.85%). Septa were present in 15 (55%) of the observed cysts. Accordingly, these were not useful in differentiating between SLC and other cystic lesions. The presence of a mural nodule, papillary projection or other solid component was detected in six out of 27 cysts (22.22%). This included the single cystadenocarcinoma and two of the four cystadenomas in the study. Calcification was present in four of the cases. Hypervascularity was a phenomenon observed in eight (29.6%). Contrast injection was followed by increased cyst wall visualization in all of the cystadenomas, but only one SLC. However, the malignant lesion did not show enhancement. Examination of the biliary duct showed proximal dilatation in six patients, but this was nondiscriminative.
Magnetic resonance imaging (MRI) was performed on six patients (21.4%), three of whom were subsequently proved to have cystadenomas on final histopathology. The one patient who was found to have a cystadenocarcinoma had no MRI examination before surgery. One patient had aspirated cyst fluid tested for CA 19-9 (with a serum CA 19-9 of 93 ng/dL) which was found to be 156 U/mL.
One patient had an incidental 10.9 cm cyst and was offered treatment due to the significant potential for cyst complications (the final histopathology revealed it to be a cystadenoma). Cyst size was recorded as the greatest cystic diameter. The largest lesion diameter ranged from 2 to 22 cm. Mean cyst size was 8.97 ± 5.11 cm for all cysts and 9.48 ± 5.15 cm for symptomatic cysts. The number of cystic lesions ranged from one to five. Twelve patients had a primary cyst in the right lobe (43%) and nine in the left lobe (32%); seven patients (25%) had bilateral cysts. Twenty patients (71.4%) had one dominant cyst and eight patients (28.6%) had several other asymptomatic cysts detected on imaging. Overall, the mean postoperative length of hospital stay was 4 days (2.38 ± 2.06 days for laparoscopic procedures and 7 ± 3.12 days for open procedures). Frozen section was performed in two cases, one of which was subse- Mean length of follow-up was 25.1 months (range 12 -104.1). There were no symptomatic recurrences. Two patients (7.14%) were observed to have asymptomatic recurrence. The asymptomatic recurrence of SLC occurred during follow-up at 2.5 and 17.4 months for open fenestration and laparoscopic fenestration procedures respectively. In these cases, both recurrences were discovered during follow-up. Neither required treatment. This is consistent with existing studies, which show that recurrences are rarely symptomatic [10] .
Discussion
Adequate differentiation of the various cystic liver disorders is necessary for directing a suitable management plan. Polycystic liver disease (PCLD) is a congenital liver disease and is diagnosed when > 20 liver cysts are present [1, 17, 18] .
A number of identifying characteristics found on US and CT investigation make it possible to distinguish SLC from most other lesions [19] . However, it can be challenging to differentiate SLC from cystadenoma and cystadenocarcinoma on imaging alone, as they can exhibit joint radiographic features [3, 4, 7, 12, 19] . In our study too, imaging failed to differentiate adequately between simple and complex cysts or between benign and malignant cystic lesions.
Among our patients, preoperative diagnosis of SLC was based on US and CT findings. Kim et al compared the CT features of cystadenoma and cystadenocarcinoma to CT features of atypical SLC that showed septation and calcification [19] . It was observed that a left lobe cyst, upstream biliary dilatation, number of cysts < 3 and a positive perilesional transhepatic attenuation difference (THAD) were predictors of malignancy [19, 20] . The atypical appearance of SLC on cross-sectional images is also attributable to previous complications such as cyst rupture, hemorrhage or infection [4, 10] .
The high rate of hepatic resection in our series may be attributed to the difficulty in ruling out complex and malignant cystic lesions by imaging and serum studies. In most series, cystadenocarcinomas and cystadenomas represent less than 5% of cystic liver lesions [1, 19] . However, in this center, they accounted for 17.8% of the total number of lesions thought to be SLC. A cystadenocarcinoma is a malignant neoplasm and therefore resection is the definitive management. Due to their potential for malignant transformation, formal resection is also advised for cystadenomas [1, 4, 21, 22] . Four of our patients were asymptomatic leading up to surgery. Two of these patients had a history of colorectal cancer (CRC). They were offered surgery because of the non-specificity of current imaging, tumor marker technology, and risk of missing a possible metachronous hepatic metastasis.
Laparoscopic fenestration is a procedure in which the roof of the cyst is removed as much as possible, draining the cyst and preventing re-accumulation of the cyst fluid. In addition, partial excision of the liver may be combined with this procedure if the cystic part of the liver is practically devoid of functional tissue. Laparoscopic fenestration provides several advantages over an open technique, including lower mortality and morbidity, reduced operative time, and shorter length of stay. Our results are consistent with the literature in this respect. Reported cyst recurrence rates following laparoscopic fenestration of SLC range between 8% and 25% [3, 5, [11] [12] [13] [14] [15] . Recurrence has been linked to incomplete unroofing, laparoscopic unroofing of a recurrent cyst which almost always has adhesions making complete deroofing difficult, deep location of the cyst and posterior segment cysts [1] . We observed one (9%) asymptomatic recurrence at 17.4 months following laparoscopic fenestration. Predictors of recurrence include incomplete fenestration, previous operative treatment, deep-seated cysts, and cysts located within the posterior liver segments [1, 13] .
Liver resection is undoubtedly a highly effective treatment alternative for the management for the majority of cystic disorders [1] . It is associated with very low recurrence rates. However, it carries a significantly greater risk for complications [11] . In our series, we performed 10 resections for SLC (four laparoscopic and six open), three resections for cystadenoma (two laparoscopic and one open) and one (open) resection for cystadenocarcinoma. The large number of resections reflects the prevalence of cyst resection as a safe and effective practice with no risk of recurrence, established over decades of experience in a long-running center like ours.
Within the laparoscopic group, there were no complications or cyst recurrence. There were no reported recurrences after open resection likewise. However, three patients did have postoperative complications after resection, which account for all such within this study. Open resection is best reserved for patients who have lesions suspicious of proliferative or malignant lesions [11] .
Laparoscopic fenestration is a safe and effective treatment modality for symptomatic SLCs. It is associated with shorter operative times, less blood loss, lower morbidity, and shorter length of hospital stay, but carries a higher recurrence rate relative to the other surgical treatment options. Omentoplasty and the use of the argon laser to coagulate the cyst wall after fenestration are reported to minimize recurrences with this technique [11] . Open fenestration should be considered for large cysts, cysts presenting difficult laparoscopic access and cysts with atypical features. Atypical features should also prompt intraoperative frozen section and, if necessary, liver resection.
This study has limitations such as a small size, relatively short period of follow-up, failure to diagnose SLC in contrast with other proliferative cystic lesions, and varying use of imaging and serum studies between patients. Its strength lies in Surgical Management of Simple Liver Cysts J Curr Surg. 2015;5(1):129-132 the inclusion of radiological recurrence and the verification of recurrence status at the time of reporting. In order to determine the optimum operative management of SLC, a randomized controlled trial utilizing both resection and fenestration in a large sample of patients presenting with this condition is required to evaluate the safety and efficacy of laparoscopic and open methods of resection and fenestration.
